2016 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting.

2016 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting. Support Care Cancer. 2017 01; 25(1):303-308.

View in: PubMed

subject areas

Antiemetics
Antineoplastic Agents
Consensus
Dose-Response Relationship, Drug
Humans
Induction Chemotherapy
Nausea
Practice Guidelines as Topic
Vomiting

authors with profiles

Rudolph Navari